Who
David B. Musket
Director
Company insider
Files Form 4 as: Director, Capricor Therapeutics; Director and 10% owner, MZT Holdings; Director, Conor Medsystems.
In numbers
- Trades disclosed
- 154
- Buys
- 5
- Sells
- 19
- Bought
- $350K
- Sold
- $27.4M
- Companies
- 3
- Companies where not an officer
- 3
- First trade
- 27 Feb 2006
- Last trade
- 5 Jan 2026
- Last filed
- 7 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Jan 2026filed 7 Jan 2026 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,500 at $0.00 | filing |
| 5 Jan 2026filed 7 Jan 2026 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,500 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,940 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,480 at $0.00 | filing |
| 2 Jan 2025filed 6 Jan 2025 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,750 at $0.00 | filing |
| 7 Aug 2024filed 9 Aug 2024 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —34,000 at $0.00 | filing |
| 7 Aug 2024filed 9 Aug 2024 | CAPR Capricor TherapeuticsBiotechnology | SEC FORM 4 Code M | $47K34,000 at $1.39 | filing |
| 23 Apr 2024filed 24 Apr 2024 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —856 at $0.00 | filing |
| 23 Apr 2024filed 24 Apr 2024 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,750 at $0.00 | filing |
| 23 Apr 2024filed 24 Apr 2024 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —1,050 at $0.00 | filing |
| 23 Apr 2024filed 24 Apr 2024 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —2,750 at $0.00 | filing |
| 23 Apr 2024filed 24 Apr 2024 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,000 at $0.00 | filing |
| 23 Apr 2024filed 24 Apr 2024 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —5,750 at $0.00 | filing |
| 23 Apr 2024filed 24 Apr 2024 | CAPR Capricor TherapeuticsBiotechnology | SEC FORM 4 Code M | $22K16,156 at $1.39 | filing |
| 2 Jan 2024filed 4 Jan 2024 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,250 at $0.00 | filing |
| 2 Jan 2024filed 4 Jan 2024 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,170 at $0.00 | filing |
| 2 Jan 2024filed 4 Jan 2024 | CAPR Capricor Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —14,280 at $0.00 | filing |
| 12 Oct 2023filed 13 Oct 2023 | CAPR Capricor TherapeuticsBiotechnology | SEC FORM 4 Bought | $1,128410 at $2.75 | filing |
| 9 Oct 2023filed 11 Oct 2023 | CAPR Capricor TherapeuticsBiotechnology | SEC FORM 4 Bought | $14K5,083 at $2.82 | filing |
| 4 Oct 2023filed 6 Oct 2023 | CAPR Capricor TherapeuticsBiotechnology | SEC FORM 4 Bought | $7,2502,500 at $2.90 | filing |
News
No headline names them, or the companies they trade most, lately.